Asterix Foods
Israel
- Tel Aviv
- 10/10/2025
- Seed
- $4,200,000
Industry leading companies like Impossible, Perfect Day (RebelBio), and EVERY (IndieBio) have shown the powerful commercial appeal of animal-free proteins. Behind this first wave comes a second wave: glycoproteins.
Glycoproteins require precise glycosylations to accurately fold, recognize, and bind – driving functional performance needed in the food industry. To unlock this second wave of animal-free proteins, Asterix Foods is using plant cells, because plant cells can easily achieve glycosylations that microbial fermentation is challenged by.
- Industry Biotechnology
- Website https://www.asterixfoods.com/
- LinkedIn https://www.linkedin.com/company/asterix-foods/
Related People
Dan EvenFounder
Israel -
Tel Aviv District
Experienced in Molecular Biology, Plant Genetic Engineering, and Plant Biology.
Specializing in: Research and Development, Biotechnology, Molecular Biology, Alternative Food & Protein, Plant Biology, Plant Genetic Engineering, Protein Purification & Expression, Antibody Engineering, Microbiology.
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)